文献速递泌尿生殖腹部MR

临床显著性前列腺癌的检测:短双脉冲序列与标准多参数MR成像的多读者研究

Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.
PubMed 文献 · Radiology · 2017-03-27

本回顾性研究纳入63例患者,比较仅含横断面T2加权和扩散加权成像的短MR方案与标准六脉冲序列多参数MR方案对临床显著性前列腺癌的检测效能。三位专家读者以五分法评估,经会阴模板饱和穿刺为参考标准,结果显示两种方案诊断效能无显著差异。

要点

  • 短双脉冲序列(横断面T2WI+DWI)与标准多参数MR对临床显著性前列腺癌的诊断效能无显著差异。
  • 短方案读者AUC范围0.74-0.81,标准方案0.71-0.77(83.8%CI重叠)。
  • 短方案敏感度0.76-0.95、特异度0.84-0.90,标准方案敏感度0.76-0.86、特异度0.82-0.90。

核心结论

  • 对于临床显著性前列腺癌的检测,仅含横断面T2加权和扩散加权成像脉冲序列的短MR成像方案与标准多参数MR成像方案的诊断效能无差异。

研究设计与样本

  • 回顾性研究,纳入2013年7月至2015年3月单中心前瞻性队列中的63例患者,使用3-T MR成像仪,短方案仅含横断面T2WI和DWI,标准方案含全部六脉冲序列,三位来自不同机构的专家读者以五分法评估,经会阴模板饱和穿刺为参考标准。

诊断标准与关键数值

  • 以经会阴模板饱和穿刺为参考标准,短方案读者AUC范围0.74-0.81(83.8%CI: 0.64, 0.89),标准方案0.71-0.77(83.8%CI: 0.62, 0.86);短方案敏感度0.76-0.95(95%CI: 0.53, 0.99),特异度0.84-0.90(95%CI: 0.79, 0.94);标准方案敏感度0.76-0.86(95%CI: 0.53, 0.97),特异度0.82-0.90(95%CI: 0.77, 0.94)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare the diagnostic performance of a short dual-pulse sequence magnetic resonance (MR) imaging protocol versus a standard six-pulse sequence multiparametric MR imaging protocol for detection of clinically significant prostate cancer. Materials and Methods This HIPAA-compliant study was approved by the regional ethics committee. Between July 2013 and March 2015, 63 patients from a prospectively accrued study population who underwent MR imaging of the prostate including transverse T1-weighted; transverse, coronal, and sagittal T2-weighted; diffusion-weighted; and dynamic contrast material-enhanced MR imaging with a 3-T imager at a single institution were included in this retrospective study. The short MR imaging protocol image set consisted of transverse T2-weighted and diffusion-weighted images only. The standard MR imaging protocol image set contained images from all six pulse sequences. Three expert readers from different institutions assessed the likelihood of prostate cancer on a five-point scale. Diagnostic performance on a quadrant basis was assessed by using areas under the receiver operating characteristic curves, and differences were evaluated by using 83.8% confidence intervals. Intra- and interreader agreement was assessed by using the intraclass correlation coefficient. Transperineal template saturation biopsy served as the standard of reference. Results At histopathologic evaluation, 84 of 252 (33%) quadrants were positive for cancer in 38 of 63 (60%) men. There was no significant difference in detection of tumors larger than or equal to 0.5 mL for any of the readers of the short MR imaging protocol, with areas under the curve in the range of 0.74-0.81 (83.8% confidence interval [CI]: 0.64, 0.89), and for readers of the standard MR imaging protocol, areas under the curve were 0.71-0.77 (83.8% CI: 0.62, 0.86). Ranges for sensitivity were 0.76-0.95 (95% CI: 0.53, 0.99) and 0.76-0.86 (95% CI: 0.53, 0.97) and those for specificity were 0.84-0.90 (95% CI: 0.79, 0.94) and 0.82-0.90 (95% CI: 0.77, 0.94) for the short and standard MR protocols, respectively. Ranges for interreader agreement were 0.48-0.60 (83.8% CI: 0.41, 0.66) and 0.49-0.63 (83.8% CI: 0.42, 0.68) for the short and standard MR imaging protocols. Conclusion For the detection of clinically significant prostate cancer, no difference was found in the diagnostic performance of the short MR imaging protocol consisting of only transverse T2-weighted and diffusion-weighted imaging pulse sequences compared with that of a standard multiparametric MR imaging protocol. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Barth BK, De Visschere PJL, Cornelius A, et al. Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. Radiology. 2017. PMID: 28346073. doi:10.1148/radiol.2017162020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。